University Hospitals Seidman Cancer Center launched a new clinical trial for CAR-T, joining a select group of hospitals offering the therapy and a smaller group of hospitals manufacturing the CAR-T cells. CAR-T therapy has been called a “living drug” and is part of a rapidly emerging immunotherapy approach called adoptive cell transfer (ACT), which collects...Continue Reading

Children treated with chimeric antigen receptor T-cell therapy experience unique toxicities that require careful monitoring to prevent serious sequalae, according to new management guidelines. An educated interdisciplinary team — including nurses, trainees, intensivists and cell therapists — is essential to identify early signs and symptoms of cytokine release syndrome (CRS) and chimeric antigen receptor (CAR)-T-cell-related...Continue Reading

Panelists: A. Keith Stewart, MB, ChB, Mayo Clinic; Sagar Lonial, MD, FACP, Emory University School of Medicine; Thomas Martin, MD, UCSF Helen Diller Family; Edward A. Stadtmauer, MD, University of Pennsylvania; Ajai Chari, MD, Mount Sinai Hospital; Amrita Krishnan, MD, FACP, City of Hope Cancer Center Published: Tuesday, Aug 14, 2018    Continue Reading

When it comes to multiple myeloma, patients’ bone health can have major implications on their outcomes – even before they are diagnosed, according to recent research conducted by Ashley Rosko, M.D. Rosko, who is an assistant professor at The Ohio State University Comprehensive Cancer Center, and her team used the Women’s Health Initiative (WHI) to...Continue Reading

A collaborative project in the UK between researchers from the University of Oxford, the University of Exeter and Chiddenbrook Surgery, Crediton, could lead to GPs using simple blood tests to improve the early diagnosis of myeloma. The study investigated the best combination of blood tests that could be used to diagnose the rare cancer within...Continue Reading